customer service in rochester or other communities inew york, very affordable.ioned she bought for under $100,000, y prices have risen about $200,000. it is still a most affordable region of the country. in midwest america we are seeing more stability because it is very able. cincinnati, indianapolis, kansas city. other fast-growing areas like florida and we know how expensive californiaarut affordability. sometimes the job market dictates where they need to be. consider the next county or the other states. stym■ according to the national associative realtors, your prediction for the market in the second half of 24 is rates predicted to remain above 6% -- mortgage ratescted to remain above 6% in 2025. median price inc. we did -- media to 400,000. home prices continue to rise. p with the numbers? guest: we looked at all of sales. mortgage numbers are a dominant driver. one ke move is we are beginning to see more inventory. changing life circumstances who conser we also have to consider 40%note mortgages. move if the circumstances dictate. forecast , the federal r

alicia: cb cotton live inew york city thank you.t nouveau for patients with alzheimer fda approved the drug researchers say it slows cognitive decline in early-stage patients. doctors now have another option to treat the degenerative brain disease. dr. marc siegel is a fox news contributor he joins us now. dr. kagan welcome. >> hi mike, good to see you. how big of a breakthrough do you consider this fda authorization for this drug that's given through monthly infusions? >> it is an improvement if something in the right direction. it gives hope to a situation where there is not a lot of hope for close to 7 million people of alzheimer's are on this country. millions and millions more trying to care for them the idea is going to go up we are lucky and probably 13 million by 2050 we've got to do something. we need tools this is a tool. because it actually targets the beta plaque protein in the brain that dunks up the ability for nerves to communicate is called a plaque protein. and by targeting it, this drug moves a step forward and get